Most Recent Articles by Da Hee Han, PharmD
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Preliminary clinical trial results show more heart-related deaths occur in patients taking febuxostat compared to allopurinol.
The American Association for the Study of Liver Diseases and the Infectious Diseases Society of America have added updates to the hepatitis C guidelines to include kidney transplant, pregnant, and pediatric patients.
The FDA has approved Opdivo (nivolumab) injection for the treatment of patients with HCC who have been previously treated with sorafenib.
The FDA has approved Adzenys ER extended-release oral suspension ADHD treatment for patients 6 years and older.